Phase II Trial of Capecitabine (Xeloda) and Weekly Docetaxel (Taxotere) in Metastatic Androgen Independent Prostate Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2012
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 20 Apr 2010 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 20 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.